Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman

19 March 2025

Interview

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Jason Dowd

18 March 2025

Interview

Addressing challenges in AAV manufacturing scale-up for cost-effective gene therapies

Andrew D Tustian

06 March 2025

Interview

Developing autologous iPSC-based therapies for Parkinson’s disease treatment

Kim Raineri

28 February 2025

Interview

Regulatory innovations: why is the UK an attractive hub for CGT development?

Rehma Chandaria

13 February 2025

Interview

Driving innovation in cell and gene therapy: the role of AI and robotics

Kenneth Harris, Mitchel Sivilotti, Anthony Rotunno

27 January 2025

Interview

Solid tumor treatment: how can we achieve therapy efficacy and persistence in the next frontier of cell therapies?

Sebastian Kobold

23 January 2025

Interview

What removing the DNA synthesis bottleneck means for the future of drug discovery and development

Elizabeth Wood

14 January 2025

Interview

Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently

Xueyuan Liu

19 December 2024

Interview

Navigating the complexities of AAV and lentiviral vector characterization

Susumu Uchiyama

12 December 2024

Interview

History and progress in viral vector particle size distribution analysis

Steven Berkowitz

09 December 2024

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

05 December 2024

Interview

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

03 December 2024

Interview

Improving lipid nanoparticle formulations for targeted delivery of genome editors

Rohit Sharma

05 November 2024

Interview

Supply chain sourcing and sustainability strategies for cell therapy and advanced biomaterial products

Raj Joshi

04 November 2024

Interview

Process optimization for AAV-based gene therapy: insights on downstream purification

Srivatsan Ramesh

17 October 2024

Interview

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Arindam Mitra

02 October 2024

Interview

Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Hari Pujar

27 September 2024

Interview

Leveraging the baculovirus-insect cell expression system for optimal AAV scale-up

Barbara Sanders, Femke Hoeksema

19 September 2024

Interview

Advancing gene therapies for β-hemoglobinopathies with novel genome and epigenome editing tools

Annarita Miccio

18 September 2024

Interview

Beyond CRISPR: exploring the next frontier in gene editing technologies

Devyn Smith

18 September 2024

Interview